Search
DaVita Inc
DVAAdd to Watchlist
207.990USD
-2.590-1.23%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
13.35BMarket Cap
19.01P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of DaVita Inc is 6.60, ranking 53 out of 76 in the Healthcare Providers & Services industry. The average price target is 140.00, with a high of 150.00 and a low of 126.00.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
193.730
Target Price
-7.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
DaVita Inc
DVA
9
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Tenet Healthcare Corp
THC
23
Natera Inc
NTRA
21
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is DaVita Inc's expected revenue for the next quarter?
DaVita Inc's expected revenue is 3.50B.
What is DaVita Inc's price target?
Analysts forecast that DaVita Inc's price target is USD 140.00, with the highest forecast at USD 150.00 and the lowest forecast at USD 126.00.
How have DaVita IncDVA's recent earnings per share performed?
The market expectation was USD 2.93, while DaVita IncDVA's earnings per share (EPS) for the previous quarter was USD 3.36. EPS for the next quarter is expected at USD 3.84.
What is the analyst rating for DaVita Inc?
Based on the ratings of DaVita Inc's stock from 9 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
